期刊文献+

高血压合并糖耐量减低患者血清瘦素水平与尿微量白蛋白的相关性 被引量:3

The Correlation between Leptin and Microalbuminuria in Hypertensive Patients with Impaired Glucose Tolerance
下载PDF
导出
摘要 目的通过分析血清瘦素水平与尿微量白蛋白、体质指数、空腹胰岛素和稳态模型评价胰岛素抵抗指数等指标的相关性,探讨其在高血压合并糖耐量减低发生机制中可能起到的作用。方法采用放射免疫法检测198例高血压病患者和47例正常对照者的血清瘦素、尿白蛋白排泄率、空腹胰岛素、血清与尿β2微球蛋白等指标。结果女性血清瘦素水平显著高于男性(P<0.001)。高血压患者中糖耐量减低者的血清瘦素水平和尿白蛋白排泄率显著高于对照组(13.6±8.0μg/L比3.87±1.48μg/L和18.8±12.5μg/min比5.47±2.19μg/min,P<0.05)及糖耐量正常者(13.6±8.0μg/L比6.08±2.03μg/L和18.8±12.5μg/min比10.0±5.2μg/min,P<0.05),低于合并糖尿病者(13.6±8.0μg/L比16.6±8.7μg/L和18.8±12.5μg/min比30.5±12.3μg/min,P<0.05)。其中肥胖者的血清瘦素水平显著高于非肥胖者(15.1±9.0μg/L比11.6±6.0μg/L,P<0.05)。尿微量白蛋白者血清瘦素水平显著高于尿白蛋白正常者(16.0±9.9μg/L比11.7±5.6μg/L,P<0.05)。本实验在控制了性别和体质因素后,糖耐量减低组的血清瘦素水平与尿白蛋白排泄率(r=0.543,P<0.001)、尿β2微球蛋白(r=0.337,P<0.01)、血清β2微球蛋白(r=0.230,P<0.05)、脉压(r=0.364,P<0.001)、胰岛素抵抗指数(r=0.325,P<0.01)、空腹胰岛素(r=0.302,P<0.01)和收缩压(r=0.290,P<0.01)呈显著正相关。多因素Backward逐步回归分析表明,性别、尿白蛋白排泄率、胰岛素抵抗指数和脉压与血清瘦素相关最显著。结论性别和体质指数是影响瘦素水平的决定性因素。高血压患者中合并IGT的发生发展是多因素综合作用的结果,此阶段可能已存在早期肾功能损伤。 Aim To examine the association between serum leptin and microalbuminturia (MA), body mass index (BMI), fasting serum insulin (FINS), homeostasis model assessment insulin resistance (HOMA-IR) and evaluate function of the correlation in mechanism of hypertension with impaired glucose tolerance (IGT). Methods This study included 198 hypertonsives and 47 healthy subjects. Hypertensives were divided into 3 groups according to their glucose tolerance: NGT, IGT and DM groups. Serum leptin, urinary albumin excretion rate (UAER), FINS, serum beta2-microglobulin (β2-MG)and urinary β2- MG concentrations were determined by radioimmunoassay. Results Baseline clinical characteristics of patients and the controls showed that serum leptin concentrations in females were significantly higher as compared with males ( P 〈 0.001). In IGT group, serum lepfin levels and UAER were higher than in control group (13.6± 8.0 μg/L vs 3.87± 1.48 μg/L and 18.8± 12. 5 μg/min vs 5.47 ± 2.19 μg/min, P〈 0.05)and NGT group (13.6± 8.0 μg/L vs 6.08±2.03 μg/L and 18.8± 12.5 μg/min vs 10.0 ±5.2 pg/min, P 〈 0.05), but lower than in DM group ( 13.6 ± 8.0 μg/L vs 16.6 ± 8.7 μg/L and 18.8 ± 12.5 μg/min vs 30.5±12.3μg/min, P〈0.05). Serum leptin concentratiom of obese patients were higher than non-obese oncs (15.1±9.0 μg/L vs 11.6±6.0μg/L, P〈0.05). Serum lepfin levels of patients with mieroalbuminmia were significanfly higher than subjects with nonnoalhaninmia(16.0±9.9μg/L vs 11.7±5.6μg/L, P〈0.05). After adjusunent for sex and the degree of body fat mass, leptin was pcsifively correlated with UAER ( r = 0.543, P 〈 0.001 ), urinary β2-MG ( r = 0.337, P 〈 0.01 ), serum β2-MG (r=0.230, P〈0.05), pulse pressure (r=0.364, P〈0.001), HOMA-IR (r=0.325, P〈0.01), FINS (r=0. 302, P 〈 0. 01 ) and systolic blood pressure ( r = 0. 290, P 〈 0. 01 ). Multiple backward regression analysis showed sex, UAER, HOMA-IR and pulse pressure wer
出处 《中国动脉硬化杂志》 CAS CSCD 2005年第5期613-618,共6页 Chinese Journal of Arteriosclerosis
关键词 内科学 高血压病合并糖耐量减低 瘦素 尿微量白蛋白 尿白蛋白排泄率 Hypertension Impaired Glucose Tolerance Lepfion Microalbuminuria Urinary Albumin Excretion Rate
  • 相关文献

参考文献2

二级参考文献10

  • 1Safar ME. Epidemiological aspects of pulse pressure and arterial stiffness[J]. J Hypertens, 1999, 17( Suppl 5):S37-S40. 被引量:1
  • 2Mitchell GF, Moye LA, Braunwald E, et al. Sphygmomanometric ally determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function[J]. Circulation,1997,96(12):4254 - 4260. 被引量:1
  • 3Cerasola G,Cottone S,Mule G,et al. Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension[J]. J Hypertens,1996,14(7) :915 -920. 被引量:1
  • 4Rodicio JL, Campoc, Ruilope LM. Microalbuminuria in essential hypertension [ J ]. Kidney Int, 1998,68 (Suppl): S51 - 54. 被引量:1
  • 5Pedrenelli R, Giampietro O, Carmassi F, et al. Microalbuminuria and endothelial dysfunction in essential hypertension[ J]. Lancet,1994, 344(8914) :14 -18. 被引量:1
  • 6Tsioufis C, Tzioumis C, Marinakis N, et al. Microalbuminuria is closely related to impaired arterial elasticity in untreated patients with essential hypertension[ J]. Nephron Exp Nephrol, 2003, 93(3) :C106 - C110. 被引量:1
  • 7Fong T M,Mol Pharmacol,1998年,53卷,234页 被引量:1
  • 8Dunbar J C,Diabetes,1997年,46卷,2040页 被引量:1
  • 9Zhang Y,Nature,1994年,372卷,425页 被引量:1
  • 10方炜,张庆怡,钱家麒,黄佩文.应用^(99m)Tc-DTPA清除率测定肾小球滤过率及与传统方法的比较研究[J].中华肾脏病杂志,1998,14(3):177-180. 被引量:37

共引文献50

同被引文献18

  • 1Hohenstein K,Watschinger B.Hypertension and the kidney.Wien Med Wochenschr,2008,158 (13-14):359-364. 被引量:1
  • 2Taglieri N,Koenig W,Kaski JC.Cystatin C and cardiovascular risk.Clin Chem,2009,55 (11):1 932-1 943. 被引量:1
  • 3Chaudhary K,Phadke G,Nistala R,et al.The emerging role of biomarkers in diabetic and hypertensive chronic kidney disease.Curr Diab Rep,2010,10(1):37-42. 被引量:1
  • 4Prats M,Font R,Bardaj A,et al.Cystatin C and cardiac hypertrophy in primary hypertension.Blood Press,2010,19(1):20-25. 被引量:1
  • 5McMurray MD,Trivax JE,McCullough PA.Serum cystatin C,renal filtration function,and left ventricular remodeling.Circ Heart Fail,2009,2(2):86-89. 被引量:1
  • 6Palatini P,Benetti E,Zanier A,et al.Cystatin C as predictor of microalbuminuria in the early stage of hypertension.Nephron Clin Pract,2009,113(4):c309-c314. 被引量:1
  • 7Wu AY,Low LP.Managing vascular risk in hypertension with a focus on microalbuminuria:attitude and practices.Singapore Med J,2009,50(10):976-981. 被引量:1
  • 8Zoccali C.Endothelial dysfunction and the kidney:emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension.J Am Soc Nephrol,2006,17(4 Suppl 2):61-63. 被引量:1
  • 9Hohenstein K, Watschinger B. Hypertension and the kidney. Wien Med Wochenschr, 2008,158 ( 13 - 14) :359 - 364. 被引量:1
  • 10Taglieri N, Koenig W, Kaski JC. Cystatin C and cardiovascular risk. Clin Chem, 2009,55 (11) :1932 -1943. 被引量:1

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部